Journal of Ovarian Research

unofficial impact factor 2.10
Search for
Advanced search
Submit a manuscript Register Sign up for article alerts

Articles

Volume 3 (2010) - June 2010

next >
up
< previous

Research   Open Access Highly Accessed

CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion

Erica L Johnson, Rajesh Singh, Crystal M Johnson-Holiday, William E Grizzle, Edward E Partridge, James W Lillard, Shailesh Singh Journal of Ovarian Research 2010, 3:15 (17 June 2010)

Abstract | Full text | PDF | PubMed |  Editor’s summary

CCR9-CCL25 signalling promotes the survival of ovarian cancer cells and resistance to the chemotherepeutic cisplatin predominately through the PI3K/Akt pathwayand PI3K inhibition negates CCL25-mediated and CCR9-dependent cisplatin resistance.

Research   Open Access Highly Accessed

Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival

Björn Nodin, Nooreldin Zendehrokh, Jenny Brändstedt, Elise Nilsson, Jonas Manjer, Donal J Brennan, Karin Jirström Journal of Ovarian Research 2010, 3:14 (17 June 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central